Kathleen Squires

Statistics

Publications

Citations

9.1K

H-Index

Active since

1988

Affiliations

Thomas Jefferson University(Current)

Harvard University

University of Southern California

University of Alabama at Birmingham

Merck & Co., Inc., Rahway, NJ, USA (United States)

Kathleen Squires is an author at Thomas Jefferson University specializing in antiretroviral therapy, antiviral therapy, and hiv antiretroviral therapy.

Publications per year

1988–2025

Publications

A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

Scott M. Hammer, Kathleen Squires, Michael D. Hughes et al. · New England Journal of Medicine · 1997 · 2.7K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

Jon H. Condra, William A. Schleif, O M Blahy et al. · Nature · 1995 · 979 citations

Life Sciences, Infectious Diseases, Molecular Biology +16

Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes

Jialing Huang, Fengxiang Wang, Elias G. Argyris et al. · Nature Medicine · 2007 · 762 citations

Life Sciences, Immunology, Molecular Biology +16

Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection

Roy M. Gulick, Heather J. Ribaudo, Cecilia M. Shikuma et al. · New England Journal of Medicine · 2004 · 528 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Initial increase in blood CD4+ lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues

R. Pat Bucy, Richard D. Hockett, Cynthia A. Derdeyn et al. · Journal of Clinical Investigation · 1999 · 334 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

1–5 of 64